Clinical Trial Update: Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating adjunctive minocycline for bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Bipolar Disorder, Bipolar Depression | Phase 3 | Status: COMPLETED